The forecast for the Penicillins and Streptomycins in Dosage market size in France shows a steady decline from 2024 to 2028. In 2023, this market stood at approximately 719 million USD. The year-on-year percentage change from 2024 to 2025 is approximately -1.94%, continuing the trend with -1.97%, -2.00%, and -2.00% in the following years, reflecting a consistent annual decrease.
From 2024 to 2028, the compound annual growth rate (CAGR) is expected to be around -1.95%, indicating an average yearly decline in market size. Future trends to watch include:
- Potential impacts of new antibiotic alternatives.
- Regulatory changes influencing pharmaceutical pricing or distribution.
- Developments in public health policies aimed at antibiotic resistance.
